Elevated ethyl methanesulfonate (EMS) in nelfinavir mesylate (Viracept<sup>®</sup>, Roche): overview
<p>Abstract</p> <p>Roche's protease inhibitor nelfinavir mesylate (Viracept<sup>®</sup>) produced between March 2007-June 2007 was found to contain elevated levels of ethyl methanesulfonate (EMS), a known mutagen (alkylator) – leading to a global recall of the drug...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-08-01
|
| Series: | AIDS Research and Therapy |
| Online Access: | http://www.aidsrestherapy.com/content/6/1/18 |